{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:06:31Z","timestamp":1792069591057,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/00984-3"],"award-info":[{"award-number":["2014\/00984-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00277-020-03978-8","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T08:02:51Z","timestamp":1583395371000},"page":"947-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia"],"prefix":"10.1007","volume":"99","author":[{"given":"Igor F.","family":"Domingos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego A.","family":"Pereira-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcondes J. V. C.","family":"Sobreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romulo T. D.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adekunle E.","family":"Alagbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Lanaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulcineia M.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria H. S. L.","family":"Blotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderson S.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio R.","family":"Lucena-Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"Sonati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos A. C.","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnun N. N.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"3978_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC (2017) Sickle cell disease. N Engl J Med 376:1561\u20131573. https:\/\/doi.org\/10.1056\/NEJMra1510865","journal-title":"N Engl J Med"},{"key":"3978_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1177\/1535370216636726","volume":"241","author":"A Habara","year":"2016","unstructured":"Habara A, Steinberg MH (2016) Minireview: genetic basis of heterogeneity and severity in sickle cell disease. Exp Biol Med (Maywood) 241:689\u2013696. https:\/\/doi.org\/10.1177\/1535370216636726","journal-title":"Exp Biol Med (Maywood)"},{"key":"3978_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","volume":"21","author":"GJ Kato","year":"2007","unstructured":"Kato GJ, Gladwin MT, Steinberg MH (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 21:37\u201347. https:\/\/doi.org\/10.1016\/j.blre.2006.07.001","journal-title":"Blood Rev"},{"key":"3978_CR4","doi-asserted-by":"publisher","first-page":"11869","DOI":"10.1073\/pnas.0804799105","volume":"105","author":"G Lettre","year":"2008","unstructured":"Lettre G, Sankaran VG, Bezerra MAC, Ara\u00fajo AS, Uda M, Sanna S, Cao A, Schlessinger D, Costa FF, Hirschhorn JN, Orkin SH (2008) DNA polymorphisms at the BCL11A, HBS1L-MYB, and -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci 105:11869\u201311874. https:\/\/doi.org\/10.1073\/pnas.0804799105","journal-title":"Proc Natl Acad Sci"},{"key":"3978_CR5","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1182\/blood-2012-06-432849","volume":"120","author":"HT Bae","year":"2012","unstructured":"Bae HT, Baldwin CT, Sebastiani P, Telen MJ, Ashley-Koch A, Garrett M, Hooper WC, Bean CJ, Debaun MR, Arking DE, Bhatnagar P, Casella JF, Keefer JR, Barron-Casella E, Gordeuk V, Kato GJ, Minniti C, Taylor J, Campbell A, Luchtman-Jones L, Hoppe C, Gladwin MT, Zhang Y, Steinberg MH (2012) Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 120:1961\u20131962. https:\/\/doi.org\/10.1182\/blood-2012-06-432849","journal-title":"Blood"},{"key":"3978_CR6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/ajh.23232","volume":"87","author":"MH Steinberg","year":"2012","unstructured":"Steinberg MH, Sebastiani P (2012) Genetic modifiers of sickle cell disease. Am J Hematol 87:795\u2013803. https:\/\/doi.org\/10.1002\/ajh.23232","journal-title":"Am J Hematol"},{"key":"3978_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/s1524-9042(02)54211-9","volume":"4","author":"WR Smith","year":"2003","unstructured":"Smith WR, Coyne P, Smith VS, Mercier B (2003) Temperature changes, temperature extremes, and their relationship to emergency department visits and hospitalizations for sickle cell crisis. Pain Manag Nurs 4:106\u2013111. https:\/\/doi.org\/10.1016\/s1524-9042(02)54211-9","journal-title":"Pain Manag Nurs"},{"key":"3978_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jemermed.2010.05.006","volume":"41","author":"AL Rogovik","year":"2011","unstructured":"Rogovik AL, Persaud J, Friedman JN, Kirby MA, Goldman RD (2011) Pediatric vasoocclusive crisis and weather conditions. J Emerg Med 41:559\u2013565. https:\/\/doi.org\/10.1016\/j.jemermed.2010.05.006","journal-title":"J Emerg Med"},{"key":"3978_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/bjh.14896","volume":"182","author":"MOS Carvalho","year":"2018","unstructured":"Carvalho MOS, Araujo-Santos T, Reis JHO, Rocha LC, Cerqueira BAV, Luz NF, Lyra IM, Lopes VM, Barbosa CG, Fiuza LM, Santiago RP, Figueiredo CVB, da Guarda CC, Barral Neto M, Borges VM, Gon\u00e7alves MS (2018) Inflammatory mediators in sickle cell anaemia highlight the difference between steady state and crisis in paediatric patients. Br J Haematol 182:933\u2013936. https:\/\/doi.org\/10.1111\/bjh.14896","journal-title":"Br J Haematol"},{"key":"3978_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","volume":"127","author":"D Zhang","year":"2016","unstructured":"Zhang D, Xu C, Manwani D, Frenette PS (2016) Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood 127:801\u2013809. https:\/\/doi.org\/10.1182\/blood-2015-09-618538","journal-title":"Blood"},{"key":"3978_CR11","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. Lancet 376:2018\u20132031. https:\/\/doi.org\/10.1016\/S0140-6736(10)61029-X","journal-title":"Lancet"},{"key":"3978_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cyto.2013.10.009","volume":"65","author":"ICJ Bandeira","year":"2014","unstructured":"Bandeira ICJ, Rocha LBS, Barbosa MC, Elias DB, Querioz JA, Freitas MV, Gon\u00e7alves RP (2014) Chronic inflammatory state in sickle cell anemia patients is associated with HBB*S haplotype. Cytokine 65:217\u2013221. https:\/\/doi.org\/10.1016\/j.cyto.2013.10.009","journal-title":"Cytokine"},{"key":"3978_CR13","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","volume":"122","author":"D Manwani","year":"2013","unstructured":"Manwani D, Frenette PS (2013) Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood 122:3892\u20133898. https:\/\/doi.org\/10.1182\/blood-2013-05-498311","journal-title":"Blood"},{"key":"3978_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ajh.20196","volume":"77","author":"A Pathare","year":"2004","unstructured":"Pathare A, Al Kindi S, Alnaqdy AA et al (2004) Cytokine profile of sickle cell disease in Oman. Am J Hematol 77:323\u2013328. https:\/\/doi.org\/10.1002\/ajh.20196","journal-title":"Am J Hematol"},{"key":"3978_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cyto.2017.12.001","volume":"107","author":"AE Alagbe","year":"2018","unstructured":"Alagbe AE, Justo Junior AS, Ruas LP et al (2018) Interleukin-27 and interleukin-37 are elevated in sickle cell anemia patients and inhibit in vitro secretion of interleukin-8 in neutrophils and monocytes. Cytokine 107:85\u201392. https:\/\/doi.org\/10.1016\/j.cyto.2017.12.001","journal-title":"Cytokine"},{"key":"3978_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03630260802625709","volume":"33","author":"N Conran","year":"2009","unstructured":"Conran N, Franco-Penteado CF, Costa FF (2009) Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin 33:1\u201316. https:\/\/doi.org\/10.1080\/03630260802625709","journal-title":"Hemoglobin"},{"key":"3978_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.hoc.2005.08.002","volume":"19","author":"EY Chiang","year":"2005","unstructured":"Chiang EY, Frenette PS (2005) Sickle cell vaso-occlusion. Hematol Oncol Clin North Am 19:771\u2013784. https:\/\/doi.org\/10.1016\/j.hoc.2005.08.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"3978_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1189\/jlb.0708445","volume":"85","author":"C Lanaro","year":"2009","unstructured":"Lanaro C, Franco-Penteado CF, Albuqueque DM et al (2009) Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J Leukoc Biol 85:235\u2013242. https:\/\/doi.org\/10.1189\/jlb.0708445","journal-title":"J Leukoc Biol"},{"key":"3978_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/10245332.2000.11746536","volume":"5","author":"T Wun","year":"2001","unstructured":"Wun T (2001) The role of inflammation and leukocytes in the pathogenesis of sickle cell disease; haemoglobinopathy. Hematology 5:403\u2013412. https:\/\/doi.org\/10.1080\/10245332.2000.11746536","journal-title":"Hematology"},{"key":"3978_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware RE, de Montalembert M, Tshilolo L, Abboud MR (2017) Sickle cell disease. Lancet (London, England) 390:311\u2013323. https:\/\/doi.org\/10.1016\/S0140-6736(17)30193-9","journal-title":"Lancet (London, England)"},{"key":"3978_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cyto.2013.11.012","volume":"65","author":"RR da Silva","year":"2014","unstructured":"da Silva RR, Pereira MC, Melo R\u00eago MJB, Domingues Hatzlhofer BL, da Silva Ara\u00fajo A, Cavalcanti Bezerra MA, da Rocha Pitta I, da Rocha Pitta MG (2014) Evaluation of Th17 related cytokines associated with clinical and laboratorial parameters in sickle cell anemia patients with leg ulcers. Cytokine 65:143\u2013147. https:\/\/doi.org\/10.1016\/j.cyto.2013.11.012","journal-title":"Cytokine"},{"key":"3978_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.hemonc.2015.11.002","volume":"9","author":"JEA Cavalcante","year":"2016","unstructured":"Cavalcante JEA, Machado RPG, Laurentino MR et al (2016) Clinical events and their relation to the tumor necrosis factor-alpha and interleukin-10 genotypes in sickle-cell-anemia patients. Hematol Oncol Stem Cell Ther 9:14\u201319. https:\/\/doi.org\/10.1016\/j.hemonc.2015.11.002","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"3978_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/CS20110340","volume":"122","author":"M Mihara","year":"2012","unstructured":"Mihara M, Hashizume M, Yoshida H et al (2012) IL-6\/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 122:143\u2013159. https:\/\/doi.org\/10.1042\/CS20110340","journal-title":"Clin Sci (Lond)"},{"key":"3978_CR24","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang S, Tanaka T, Narazaki M, Kishimoto T (2019) Targeting interleukin-6 signaling in clinic. Immunity 50:1007\u20131023. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.026","journal-title":"Immunity"},{"key":"3978_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bjhh.2015.07.006","volume":"37","author":"BS Pierrot-Gallo","year":"2015","unstructured":"Pierrot-Gallo BS, Vicari P, Matsuda SS, Adegoke SA, Mecabo G, Figueiredo MS (2015) Haptoglobin gene polymorphisms and interleukin-6 and -8 levels in patients with sickle cell anemia. Rev Bras Hematol Hemoter 37:329\u2013335. https:\/\/doi.org\/10.1016\/j.bjhh.2015.07.006","journal-title":"Rev Bras Hematol Hemoter"},{"key":"3978_CR26","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1089\/jir.1995.15.1061","volume":"15","author":"SC Taylor","year":"1995","unstructured":"Taylor SC, Shacks SJ, Mitchell RA, Banks A (1995) Serum interleukin-6 levels in the steady state of sickle cell disease. J Interf Cytokine Res 15:1061\u20131064. https:\/\/doi.org\/10.1089\/jir.1995.15.1061","journal-title":"J Interf Cytokine Res"},{"key":"3978_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/153537020523000109","volume":"230","author":"JM Hibbert","year":"2005","unstructured":"Hibbert JM, Hsu LL, Bhathena SJ, Irune I, Sarfo B, Creary MS, Gee BE, Mohamed AI, Buchanan ID, al-Mahmoud A, Stiles JK (2005) Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med (Maywood) 230:68\u201374. https:\/\/doi.org\/10.1177\/153537020523000109","journal-title":"Exp Biol Med (Maywood)"},{"key":"3978_CR28","doi-asserted-by":"publisher","unstructured":"Costa MFH, Torres LC, da Matta MC et al (2019) Interleukin-6 in pregnancy with sickle cell disease. Hematol Transfus Cell Ther. https:\/\/doi.org\/10.1016\/j.htct.2019.02.001","DOI":"10.1016\/j.htct.2019.02.001"},{"key":"3978_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cyto.2014.11.030","volume":"72","author":"S Sarray","year":"2015","unstructured":"Sarray S, Saleh LR, Lisa Saldanha F, al-Habboubi HH, Mahdi N, Almawi WY (2015) Serum IL-6, IL-10, and TNF\u03b1 levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition. Cytokine 72:43\u201347. https:\/\/doi.org\/10.1016\/j.cyto.2014.11.030","journal-title":"Cytokine"},{"key":"3978_CR30","doi-asserted-by":"publisher","unstructured":"Van Beers EJ, Yang Y, Raghavachari N, Tian X, Allen DT, Nichols JS, Mendelsohn L, Nekhai S, Gordeuk VR, Taylor 6th JG, Kato GJ (2015) Iron, inflammation, and early death in adults with sickle cell disease. Circ Res 116:298\u2013306. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.304577","DOI":"10.1161\/CIRCRESAHA.116.304577"},{"key":"3978_CR31","doi-asserted-by":"publisher","unstructured":"Zahran AM, Nafady A, Saad K et al (2020) Effect of hydroxyurea treatment on the inflammatory markers among children with sickle cell disease. Clin Appl Thromb Hemost 26. https:\/\/doi.org\/10.1177\/1076029619895111","DOI":"10.1177\/1076029619895111"},{"key":"3978_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jlb.56.5.559","volume":"56","author":"A Harada","year":"1994","unstructured":"Harada A, Sekido N, Akahoshi T et al (1994) Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56:559\u2013564. https:\/\/doi.org\/10.1002\/jlb.56.5.559","journal-title":"J Leukoc Biol"},{"key":"3978_CR33","doi-asserted-by":"publisher","unstructured":"Xie K (2001) Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12:375\u2013391. https:\/\/doi.org\/10.1016\/s1359-6101(01)00016-8","DOI":"10.1016\/s1359-6101"},{"key":"3978_CR34","doi-asserted-by":"publisher","first-page":"e7956","DOI":"10.1371\/journal.pone.0007956","volume":"4","author":"X Niu","year":"2009","unstructured":"Niu X, Nouraie M, Campbell A, Rana S, Minniti CP, Sable C, Darbari D, Dham N, Reading NS, Prchal JT, Kato GJ, Gladwin MT, Castro OL, Gordeuk VR (2009) Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease. PLoS One 4:e7956. https:\/\/doi.org\/10.1371\/journal.pone.0007956","journal-title":"PLoS One"},{"key":"3978_CR35","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1590\/s0100-879x2001001000011","volume":"34","author":"MS Gon\u00e7alves","year":"2001","unstructured":"Gon\u00e7alves MS, Queiroz IL, Cardoso SA et al (2001) Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease. Brazilian J Med Biol Res = Rev Bras Pesqui medicas e Biol 34:1309\u20131313. https:\/\/doi.org\/10.1590\/s0100-879x2001001000011","journal-title":"Brazilian J Med Biol Res = Rev Bras Pesqui medicas e Biol"},{"key":"3978_CR36","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2018.017","volume":"10","author":"AE Alagbe","year":"2018","unstructured":"Alagbe AE, Olaniyi JA, Aworanti OW (2018) Adult sickle cell anaemia patients in bone pain crisis have elevated pro-inflammatory cytokines. Mediterr J Hematol Infect Dis 10:e2018017. https:\/\/doi.org\/10.4084\/MJHID.2018.017","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"3978_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/20469047.2018.1519988","volume":"38","author":"SA Adegoke","year":"2018","unstructured":"Adegoke SA, Kuti BP, Omole KO, Smith OS, Oyelami OA, Adeodu OO (2018) Acute chest syndrome in sickle cell anaemia: higher serum levels of interleukin-8 and highly sensitive C-reactive proteins are associated with impaired lung function. Paediatr Int Child Health 38:244\u2013250. https:\/\/doi.org\/10.1080\/20469047.2018.1519988","journal-title":"Paediatr Int Child Health"},{"key":"3978_CR38","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2141.2000.02358.x","volume":"111","author":"MR Abboud","year":"2008","unstructured":"Abboud MR, Taylor EC, Habib D et al (2008) Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol 111:482\u2013490. https:\/\/doi.org\/10.1111\/j.1365-2141.2000.02358.x","journal-title":"Br J Haematol"},{"key":"3978_CR39","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cyto.2011.07.002","volume":"56","author":"C Cajado","year":"2011","unstructured":"Cajado C, Cerqueira BAV, Couto FD et al (2011) TNF-alpha and IL-8: serum levels and gene polymorphisms (-308G>A and -251A>T) are associated with classical biomarkers and medical history in children with sickle cell anemia. Cytokine 56:312\u2013317. https:\/\/doi.org\/10.1016\/j.cyto.2011.07.002","journal-title":"Cytokine"},{"key":"3978_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jdiacomp.2015.10.002","volume":"30","author":"K Singh","year":"2016","unstructured":"Singh K, Agrawal NK, Gupta SK et al (2016) Increased expression of TLR9 associated with pro-inflammatory S100A8 and IL-8 in diabetic wounds could lead to unresolved inflammation in type 2 diabetes mellitus (T2DM) cases with impaired wound healing. J Diabetes Complicat 30:99\u2013108. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.10.002","journal-title":"J Diabetes Complicat"},{"key":"3978_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1469-0691.2009.02793.x","volume":"16","author":"MC Peral","year":"2010","unstructured":"Peral MC, Rachid MM, Gobbato NM, Huaman Martinez MA, Valdez JC (2010) Interleukin-8 production by polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated with Lactobacillus plantarum. Clin Microbiol Infect 16:281\u2013286. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02793.x","journal-title":"Clin Microbiol Infect"},{"key":"3978_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajh.23571","volume":"89","author":"CP Minniti","year":"2014","unstructured":"Minniti CP, Delaney K-MH, Gorbach AM et al (2014) Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia. Am J Hematol 89:1\u20136. https:\/\/doi.org\/10.1002\/ajh.23571","journal-title":"Am J Hematol"},{"key":"3978_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399409000945","volume":"11","author":"L Pradhan","year":"2009","unstructured":"Pradhan L, Nabzdyk C, Andersen ND et al (2009) Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med 11:1\u201324. https:\/\/doi.org\/10.1017\/S1462399409000945","journal-title":"Expert Rev Mol Med"},{"key":"3978_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/jsre.2000.5892","volume":"93","author":"HO Rennekampff","year":"2000","unstructured":"Rennekampff HO, Hansbrough JF, Kiessig V, Dor\u00e9 C, Sticherling M, Schr\u00f6der JM (2000) Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 93:41\u201354. https:\/\/doi.org\/10.1006\/jsre.2000.5892","journal-title":"J Surg Res"},{"key":"3978_CR45","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0002-9440(10)65699-4","volume":"153","author":"E Engelhardt","year":"1998","unstructured":"Engelhardt E, Toksoy A, Goebeler M, Debus S, Br\u00f6cker EB, Gillitzer R (1998) Chemokines IL-8, GRO\u03b1, MCP-1, IP-10, and mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 153:1849\u20131860. https:\/\/doi.org\/10.1016\/S0002-9440(10)65699-4","journal-title":"Am J Pathol"},{"key":"3978_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbt.22351","volume":"33","author":"L Meng","year":"2019","unstructured":"Meng L, Guo X, Yang X et al (2019) Human \u03b1 defensins promote the expression of the inflammatory cytokine interleukin-8 under high-glucose conditions: novel insights into the poor healing of diabetic foot ulcers. J Biochem Mol Toxicol 33:1\u20138. https:\/\/doi.org\/10.1002\/jbt.22351","journal-title":"J Biochem Mol Toxicol"},{"key":"3978_CR47","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1182\/blood-2002-02-0620","volume":"101","author":"V Regnault","year":"2003","unstructured":"Regnault V, de Maistre E, Carteaux J-P, Gruel Y, Nguyen P, Tardy B, Lecompte T (2003) Platelet activation induced by human antibodies to interleukin-8. Blood 101:1419\u20131421. https:\/\/doi.org\/10.1182\/blood-2002-02-0620","journal-title":"Blood"},{"key":"3978_CR48","doi-asserted-by":"publisher","first-page":"32188","DOI":"10.1038\/srep32188","volume":"6","author":"J Bester","year":"2016","unstructured":"Bester J, Pretorius E (2016) Effects of IL-1\u03b2, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity. Sci Rep 6:32188. https:\/\/doi.org\/10.1038\/srep32188","journal-title":"Sci Rep"},{"key":"3978_CR49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/jlb.59.4.489","volume":"59","author":"G Fantuzzi","year":"1996","unstructured":"Fantuzzi G, Dinarello CA (1996) The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice. J Leukoc Biol 59:489\u2013493. https:\/\/doi.org\/10.1002\/jlb.59.4.489","journal-title":"J Leukoc Biol"},{"key":"3978_CR50","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/MPH.0b013e3181acd89d","volume":"31","author":"AA Wanderer","year":"2009","unstructured":"Wanderer AA (2009) Rationale for IL-1beta targeted therapy for ischemia-reperfusion induced pulmonary and other complications in sickle cell disease. J Pediatr Hematol Oncol 31:537\u2013538. https:\/\/doi.org\/10.1097\/MPH.0b013e3181acd89d","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03978-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-020-03978-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03978-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:13:17Z","timestamp":1614903197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-020-03978-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["3978"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-03978-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"1 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}